CD274 and cancer: More recently, zero valent iron (ZVI) NPs have also been revealed as potential immune modulators to augment anticancer immunity by switching protumor M2 macrophages into antitumor M1 macrophages, minimizing the population of regulatory T cells and attenuating PD-L1 expression in cancer cells 97.